SOPH
SOPHiA GENETICS SA
Company Overview
| Mkt Cap | $273.34M | Price | $5.00 |
| Volume | 157.22K | Change | -3.66% |
| P/E Ratio | -4.4 | Open | $5.26 |
| Revenue | $65.2M | Prev Close | $5.19 |
| Net Income | $-62.5M | 52W Range | $2.58 - $5.30 |
| Div Yield | N/A | Target | $7.00 |
| Overall | 66 | Value | -- |
| Quality | 42 | Technical | 90 |
No chart data available
Stock Overview
Updated DailySOPHiA GENETICS SA (SOPH) is a leading Professional, Scientific, and Technical Services company in the Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) industry, currently trading at $5.00 with a market capitalization of $273.34 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating below-average quality metrics with a MarketXLS quality score of 42.
Today's trading session shows SOPH with a volume of 157K shares. The stock opened up 1.35% from yesterday's close of $5.19. Current analyst estimates project earnings of $NA per share for this year, with next year targeting $NA.
SOPH demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including PFSF, PGFY, PHR, PERK-CA.
Key investment considerations for SOPH include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 40.0%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:29 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SOPH | $5.00 | -3.7% | 157.22K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |